Round Two of the REDI Contestable Program (REDIC2.0) Is Closed
MTPConnect’s Researcher Exchange and Development within Industry (REDI) is a four-year, $32 million initiative funded by the Medical Research Future Fund (MRFF) that aims to deliver system-wide improvements to skills development and training programs for the MTP workforce.
In delivering the REDI program, MTPConnect is partnering with research, training and industry organisations to deploy an integrated three-pillar plan driving skills and workforce development for the MTP sector nationally.
REDIC 2.0 is now calling for suitably qualified organisations to submit proposals for new training and education programs. This is to address specific priority skills gaps identified in a ‘root and branch’ analysis and published recently in the report, 'Driving skills development and workforce training for the future MTP workforce'.
- Proposal 1: Identifying unmet market need and understanding the clinical context
- Proposal 2: Ability to secure investment, funding and/or industry collaboration - Delivering on your Funding Strategy
The REDI Information Session is now available to view as an on-demand video below.
Submit your application using the online portal. The portal allows you to apply and download the latest copy of the application form.
Before you apply please make sure you have read the Resources for Applicants.
Please send any questions via email to REDIC.email@example.com.
REDIC1.0 called for proposals for new training and education programs to address two specific priority skills gaps identified in the REDI Skills Gap Analysis Interim Report.
- Understanding of quality management systems and protocols; and
- Strategic clinical trial design to meet regulatory requirements and payer needs.
The REDI initiative has awarded Round One contracts to ARCS Australia and SeerPharma for these workforce skills gap training and education programs.
ARCS Australia will deliver training workshops in Melbourne and Sydney to address skills gaps relating to the strategic design of clinical trials to meet regulatory and payer needs for pharmaceuticals and medical devices.
ARCS Australia Ltd is a national, membership-based organisation focused on the development and growth of the healthcare sector. ARCS provides education, career pathways, professional development and advocacy to the sector. ARCS and its members are dedicated to improving the quality of life of healthcare consumers.
Visit ARCS Australia for more information.
LinkedIn: ARCS Australia
SeerPharma will deliver a range of programs online and in capital cities to address skills gaps relating to quality management systems and protocols.
SeerPharma is a team of consultants that provide advice, training, software solutions from MasterControl, and contract labour resources to pharmaceutical, medical device and life science companies in the Asia-Pacific region, on matters of Quality Assurance and GMP compliance.
Visit SeerPharma for more information.